These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1451 related articles for article (PubMed ID: 33081731)
1. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. Zhang F; Liu Y; Yang Y; Yang K BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer. Jin Y; Wang L; Lou H; Song C; He X; Ding M Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277 [TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma. Li N; Yu K; Lin Z; Zeng D Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416 [TBL] [Abstract][Full Text] [Related]
4. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma. Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622 [TBL] [Abstract][Full Text] [Related]
5. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma. Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058 [TBL] [Abstract][Full Text] [Related]
6. Seven Immune-Related Genes' Prognostic Value and Correlation with Treatment Outcome in Head and Neck Squamous Cell Carcinoma. Mu R; Shen Y; Guo C; Zhang X; Yang H; Yang H Mediators Inflamm; 2023; 2023():8533476. PubMed ID: 39282247 [TBL] [Abstract][Full Text] [Related]
7. A Signature of N Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X Front Immunol; 2022; 13():809872. PubMed ID: 35185897 [TBL] [Abstract][Full Text] [Related]
8. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma. Yang C; Mei H; Peng L; Jiang F; Xie B; Li J Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497 [TBL] [Abstract][Full Text] [Related]
10. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma. Fang R; Iqbal M; Chen L; Liao J; Luo J; Wei F; Wen W; Sun W Aging (Albany NY); 2021 Apr; 13(8):11507-11527. PubMed ID: 33867351 [TBL] [Abstract][Full Text] [Related]
11. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
12. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma. Zhang J; Shi X; Wang M; Zhai R; Wang M; Gong Z; Ni Z; Xu T; Zhu W; Liu L J Cancer Res Clin Oncol; 2024 May; 150(5):240. PubMed ID: 38713284 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma. Ding Z; Li H; Yu D Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3973-3983. PubMed ID: 33449166 [TBL] [Abstract][Full Text] [Related]
15. Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma. Pan Y; Song Y; Cheng L; Xu H; Liu J J Cell Biochem; 2019 Dec; 120(12):19482-19495. PubMed ID: 31264288 [TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets. Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443 [TBL] [Abstract][Full Text] [Related]
17. Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma. Huang J; Xu Z; Wang Z; Zhou C; Shen Y Curr Cancer Drug Targets; 2024; 24(8):804-819. PubMed ID: 38310463 [TBL] [Abstract][Full Text] [Related]
18. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
19. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. Chen L; He X; Yi S; Liu G; Liu Y; Ling Y Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816 [TBL] [Abstract][Full Text] [Related]
20. ANXA5 predicts prognosis and immune response and mediates proliferation and migration in head and neck squamous cell carcinoma. Yang D; Chen H; Zhou Z; Guo J Gene; 2024 Dec; 931():148867. PubMed ID: 39168258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]